Myriam Vézain

903 citations
13 papers · 462 indexed · h-index 9
Topics
RNA Research and Splicing (6 papers)RNA modifications and cancer (4 papers)Neurogenetic and Muscular Disorders Research (4 papers)
Partner nations
FranceItalyUnited States

In The Last Decade

Myriam Vézain

13 papers receiving 461 citations

Peers

Myriam Vézain
Comparison fields: 5 of 46
  • Molecular Biology 352
  • Genetics 123
  • Genetics 109
  • Cancer Research 81
  • Pathology and Forensic Medicine 76
Replace Stef van Lieshout with:
Stef van Lieshout Netherlands
Fatema Alzahrani Saudi Arabia
Katsumi Harada Japan
Rachel Soemedi United States
Huarui Zheng China
Lauren A. Solomon Canada
Paula Aldaz Spain
Mahmoud Mansouri Sweden
Anna Abramowicz Poland
Jennifer B. Edwards United States
Myriam Vézain relative to Stef van Lieshout Netherlands Stef van Lieshout's profile →
Citations per field
00.5×3.6×
Stef van Lieshout · 1×
Citations per year

Countries citing papers authored by Myriam Vézain

Since Specialization
Citations

This map shows the geographic impact of Myriam Vézain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Myriam Vézain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Myriam Vézain more than expected).

Fields of papers citing papers by Myriam Vézain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Myriam Vézain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Myriam Vézain. The network helps show where Myriam Vézain may publish in the future.

Co-authorship network of co-authors of Myriam Vézain

This figure shows the co-authorship network connecting the top 25 collaborators of Myriam Vézain. A scholar is included among the top collaborators of Myriam Vézain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Myriam Vézain. Myriam Vézain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 4
2 2
3 2
4 15
5 16
6 5
7 14
8 51
9 17
10 89
11 89
12 126
13 32

About Myriam Vézain

Myriam Vézain is a scholar working on Genetics, Cancer Research and Urology, having authored 13 papers that have together received 462 indexed citations. Recurring topics across this work include RNA Research and Splicing (6 papers), RNA modifications and cancer (4 papers) and Neurogenetic and Muscular Disorders Research (4 papers). The work is most often cited by research in Genetics (123 citations), Cancer Research (81 citations) and Molecular Biology (352 citations). Myriam Vézain has collaborated with scholars based in France, Italy and United States. Frequent co-authors include Mario Tosi, Alexandra Martins, Thierry Frébourg, Isabelle Tournier, Pascale Saugier-Véber, Françoise Charbonnier, Qing Wang, Johann Soret, Jamal Tazi and Sylviane Olschwang. Their work appears in journals such as Molecular Cell, Journal of Medical Genetics and Human Mutation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026